ArrantaBio’s Staff Cares
December 19, 2022
An early look at ArrantaBio’s newly-designed “Staff Cares” logo, typically used during cultural events and recruiting outreach programs.
GBI Rebranding
December 1, 2022
Goodwin Biotechnologies has rebranded as GBI with a brand new website. Congratulations to all the staff in Florida — We’re looking forward to seeing the new brand flourish!
Lacoste 2022 Branding
November 21, 2022
Lacoste was founded in 1933, and is experiencing a new era of growth. With that comes a new seasonal brand launch.
Aston Villa
November 11, 2022
We’re really digging Aston Villa’s new branding. The updated logo represents a crucial step forward as the nearly 150-year-old club enters a new era of growth.
Nu-Tek BioSciences
August 29, 2022
Thomas Yezzi, Founder & CEO of Nu-Tek BioSciences, cut the ribbon on a state-of-the art Peptone Protein facility in Austin, Minnesota.
No Poison, Just Ivy
May 1, 2022
Sarah made a new friend! Eight-year-old Ivy is helping her keep tabs on That's Nice Tennessee.
HEY COOL CAT
May 1, 2022
The new That's Nice location in Tennessee is the cat's meow...just ask Sarah! This 16-year-old feline keeps a close watch on what's happening at That's Nice's southern outpost.
Old Glassware For Our Lab
April 1, 2022
Even when you're exploring the future, It doesn't hurt to go "old school" every now and then...
Cannabis used by Lilly
April 1, 2022
Think CBD is a new trend? This vintage Eli Lilly bottle says otherwise. See if you can spot it on the next Pharma's Almanac TV!
1964 Microscope Instruction Guide
March 31, 2022
What makes a microscope from 1964 even better? How about a microscope instruction book from 1964? Who says a dollar doesn't buy anything?
1970’s Microscope Just Arrived
March 30, 2022
Coming Soon to Pharma's Almanac TV: Our interview studio is getting a makeover. See if you can spot this vintage microscope when our next video emanates from the Pharma's Almanac "lab!"
Don Carroll joins That's Nice as Senior Marketing Copywriter
March 18, 2022
That's Nice is excited to announce Don Carroll joins us as the newest addition to our Strategic Content team under Mark Allen. Don has two decades of experience as the copy lead for T&Co., Sotheby's, The Metropolitan Museum of Art, Bergdorf Goodman, Barnes & Noble, Inc., and Bloomingdale's. He was also director of ideation at the pioneering social commerce agency dotbox. Don is a graduate of Vassar College and Yale University. When not writing copy, he makes waves in the art world as an artist, curator, and critic. He was the founding editor of Art Lies magazine and co-founder and director for a decade of the legendary Jack the Pelican Presents gallery. After his first foray into healthcare with Planned Parenthood, he’s never looked back. Welcome, Don!
John DeGregorio Jr. joins That’s Nice as Associate Marketing Copywriter
March 15, 2022
We are delighted to announce that John DeGregorio Jr. has joined That’s Nice as an Associate Marketing Copywriter. Prior to joining That’s Nice, John was a freelance finance copywriter and social media content creator. John graduated from Rutgers University with a BA in Journalism & Media Studies. Joining our rapidly growing Strategic Content team — headed by Strategy Director Mark Allen — John will be supporting our clients’ marketing and messaging needs through the development of marketing content across formats and channels. Welcome, John!
Elliot Olshansky Joins That's Nice as Marketing Copywriter
March 14, 2022
That’s Nice is happy to welcome Elliot Olshansky to the team. Elliot joins That’s Nice as a Marketing Copywriter and will support our clients’ marketing and messaging needs through the development of marketing content across formats and channels. Elliot has extensive experience in communications, serving as the Assistant Director of Communications for Long Island University and Advancement Communications Writer at Stony Brook University. Prior to joining the copywriting team at That’s Nice, Eliot was a senior copywriter for Austin Williams. Elliot has a BA in Government from Dartmouth College and an MBA from Fordham University. Elliot is joining our quickly growing Strategic Content team working with our Strategy Director, Mark Allen. Welcome, Elliot!
Welcome Jim Grote
February 3, 2022
James Grote joins That’s Nice as Director of Research We are thrilled to announce that James (Jim) Grote has joined That’s Nice as our new Director of Research. Jim has a long history within the pharmaceutical industry, beginning in 1996 at Schering Plough Corp., where he served in a variety of roles within the Market Research, Global Business Analytics, and U.S. Core Analytics groups for 15 years. Following a senior manager position in Market Research at Mylan Specialty, Jim moved to the vendor side of the business with a stint at IMS Health/IQVIA. Jim’s most recent role was at Celgene/BMS, assisting in a project management position as the company ramped up its readiness to manufacture its new CAR-T therapy for treatment of multiple myeloma. Jim will be looking to help build the Research department at That’s Nice as the company continues to expand its scope and better serve its client base. Welcome, Jim!
Welcome, Danielle Alvarez!
January 28, 2022
The That’s Nice and Pharma’s Almanac teams are delighted to announce the introduction of Danielle Alvarez as the new Associate Scientific Editor for Pharma’s Almanac and Project Manager for That’s Nice. Danielle studied biology at Brown University and additionally brings marketing experience in support of the publication. Danielle is the first new addition in what will be a significant expansion of the Pharma’s Almanac team in 2022, further growing our resources in scientific content and market research under Editor in Chief David Alvaro. Danielle will support all aspects of our thought leadership platform, including interviews, articles, our Pharma’s Almanac TV video series, market research reports, and a number of new initiatives launching soon. Welcome aboard, Danielle!
Jonathan Sismey, Sales Manager
January 27, 2022
Jonathan Sismey is joining That's Nice and Pharma's Almanac as a Sales Manager. This is his second stint with the company after a 14-year absence. Jonathan brings 30 years of sales experience to the company, having worked as a media representative for several major publishing groups in the United States and Europe. During this time his focus was in the pharmaceutical, chemical, biotechnology, drug discovery, and mechanical engineering sectors. At Pharma's Almanac, Jonathan will work on new business opportunities associated with publishing in the life science industry and related services. Welcome, Jonathan!
Welcome to That's Nice Danielle
January 3, 2022
Danielle Alvarez has joined the That's Nice team and will be working closely with the Pharma's Almanac publication. Starting 2022 off on the right foot.
Stay Tuned for the Latest
April 13, 2017
The newest ad from our Glittering Insights series has been released! Be on the lookout for the campaign’s signature pop art in upcoming industry publications.
New client case study launches – CMC Biologics
March 31, 2017
Seeking to further differentiate its capabilities within the biopharmaceutical CDMO market, CMC Biologics engaged us to help convey its experience, flexibility, and innovation in delivering ‘right-on-time’ solutions. View Case Study >
New client case study launches – Servier CDMO
March 29, 2017
Leveraging its 11 global facilities, Servier Laboratories developed an embedded CDMO business and engaged That’s Nice to help market the company’s excess capacity to other pharmaceutical manufacturers. View Case Study >
New client case study launches – Cenexi
March 29, 2017
That’s Nice worked with Cenexi to optimize awareness of the brand’s robust CDMO business and sterile oncology capabilities while emphasizing the company’s history of innovation. View Case Study >
New client case study launches – Icagen
March 28, 2017
Following a series of organizational changes resulting in an expansion of both space and capacity, That’s Nice worked with Icagen to create a unified brand that wholly conveyed the company’s robust capabilities in early discovery. View Case Study >